Zfp296 was originally discovered as an oncogene candidate from a leukemic mouse model15–17 and was also identified as the translocation breakpoint in t(17;19)(q23;q13.32) pediatric acute myeloid leukemia (AML)18. Here, ZNF296 is linked to acute myeloid leukemia.